A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...

Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs. By Jan Hoffman The message ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

Hidden Creek Wellness Retreat supports adolescents struggling with substance use through therapy, recovery programs, ...

Social rank regulates methamphetamine-seeking behavior by modulating the mesocortical and mesolimbic dopamine pathways, and winning experiences can remodel these circuits to suppress drug-seeking. In ...

Tracking over 600,000 veterans shows that GLP-1 receptor agonists are linked to lower rates of substance use disorders, fewer overdoses, and fewer addiction-related hospital visits.

The massively popular drugs known as GLP-1 agonists could even halve people's risk of dying from a range of harmful substances, according to the research published in the BMJ journal.

A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.